Clinical and experimental evidence support a cause–effect relationship between altered insulin signaling and development of kidney disease of metabolic and non-metabolic origin. However, the current criteria to measure and/or estimate the insulin resistance (IR) are available as research tool but are very difficult to implement in the clinical practice. Therefore, a better understanding of the key players contributing to IR may lead to the development of new non-invasive tools to assess organ-specific insulin sensitivity (IS). We will therefore first introduce the concept that IR and kidney disease may be causally linked as suggested by clinical and experimental studies. We will then, expand on the potential mechanisms leading to altered renal insulin signaling. After reviewing the limitation of currently available strategies to determine IR, this review article will focus on imaging techniques that could be utilized to determine renal IR and that could be tested to predict kidney disease development and progression.
Skip Nav Destination
Article navigation
June 2018
-
Cover Image
Cover Image
Double immunofluorescence staining for mindin (red) and CD68 (green) in atherosclerotic plaques of HFD-treated APOE-/- mice. In Issue 11 of Clinical Science, Zhu et al. discuss mindin deficiency as a novel mediator in protecting against foam cell formation and atherosclerosis, through direct interaction with LXR-β; for details, see pages 1199–1213.
Review Article|
June 05 2018
Probing insulin sensitivity in diabetic kidney disease: is there a stronger role for functional imaging?
Michael L. Granda;
Michael L. Granda
1Department of Medicine, Jackson Memorial Hospital, University of Miami, 1611 NW 12th Ave, Miami, FL 33136, U.S.A.
2Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami, Miami, FL, U.S.A.
Search for other works by this author on:
Pooja Amarapurkar;
Pooja Amarapurkar
1Department of Medicine, Jackson Memorial Hospital, University of Miami, 1611 NW 12th Ave, Miami, FL 33136, U.S.A.
2Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami, Miami, FL, U.S.A.
Search for other works by this author on:
Alessia Fornoni
2Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami, Miami, FL, U.S.A.
3Peggy and Harold Katz Family Drug Discovery Center, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
Correspondence: Alessia Fornoni ([email protected])
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
March 12 2018
Revision Received:
April 25 2018
Accepted:
May 09 2018
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society
2018
Clin Sci (Lond) (2018) 132 (11): 1085–1095.
Article history
Received:
March 12 2018
Revision Received:
April 25 2018
Accepted:
May 09 2018
Citation
Michael L. Granda, Pooja Amarapurkar, Alessia Fornoni; Probing insulin sensitivity in diabetic kidney disease: is there a stronger role for functional imaging?. Clin Sci (Lond) 14 June 2018; 132 (11): 1085–1095. doi: https://doi.org/10.1042/CS20171490
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.